Navigation Links
Warren Lammert Joins IntelliMedix Board of Advisors
Date:2/27/2013

ATLANTA, Feb. 27, 2013 /PRNewswire-iReach/ -- IntelliMedix announced that Warren Lammert has been appointed to its Board. Lammert is the Chairman and co-founder of the Epilepsy Therapy Project and Epilepsy.com and is also a board member for FACES (Finding a Cure for Epilepsy and Seizures) at New York University.

"Warren brings an impressive track record accelerating innovation for new therapies in the field of epilepsy.  Warren's drive, passion and proven business acumen will be a great contribution to the Intellimedix team.  Warren will help us achieve our goal of finding cures for Dravet Syndrome, epilepsy and other neurological disorders. We are fortunate and excited to have him on board," said Daniel Fischer , President and CEO of Intellimedix.

Mr. Lammert is Founder, Principal and Chief Investment Officer of Granite Point Capital and has more than 18 years of investment industry experience. Prior to the formation of Granite Point Capital, he spent 14 years at Janus serving in several investment and senior management roles, including most recently, Portfolio Manager of the Janus Mercury Fund from its inception in 1993 until March 2003.

"I am thrilled to join with Intellimedix in working to build new approaches to drug discovery for Dravet Syndrome and other orphan and human diseases.  Jim Jacoby and Daniel Fischer have assembled a team with a remarkable breadth of expertise but what impresses me most is the range of effective collaborative partnerships that the Intellimedix team has built and nurtured around key emerging discovery technologies," said Warren Lammert .

Also sitting on the Board is Jim Jacoby , Chairman of the Board for IntelliMedix and CEO of Jacoby Development.

About IntelliMedix:

I
'/>"/>

SOURCE IntelliMedix
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. FASEB joins President Obama in urging Congress to sustain investments in research and innovation
2. Book shows evolution that joins human and environmental sciences
3. Brazil joins global initiative for biodiversity data access
4. Advanced Clinical Joins MedNet Solutions iMedNet Partner Program
5. Brazil joins international marine research effort
6. Steve Fisher joins American Health IT LLC as VP of Operations
7. Hass Avocado Board study published in Food & Function journal
8. Medbox Communicates with Shareholders, Comments on Pending Transition to OTC Bulletin Board, and Announces Appearance on Fox Business News Channel
9. JoVE establishes Librarian Advisory Board
10. Diving board sensors key to DNA detection
11. Ken Bierly of the Oregon Watershed Enhancement Board to receive ESA Regional Policy Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... OXFORD, Conn. , Apr. 1, 2015  NXT-ID, ... a biometric authentication company focused on the growing mobile ... number of Wocket smart wallets is underway to early ... early access group includes usage at retail outlets including ... CVS Pharmacy. Users report Wocket was accepted at all ...
(Date:3/30/2015)... DUBLIN , Mar. 26, 2015 Research and ... addition of the "Global Gesture Recognition Market in ... The analysts forecast the Global Gesture Recognition market ... 12.8% over the period 2013-2018. Gesture recognition ... respond to different gestures of an individual. Gesture recognition ...
(Date:3/24/2015)... , March 24, 2015   NexID Biometrics ... with critical security-authentication needs, today announced the beginning of ... (FFD) solution. The company, based in ... at the three-day Connect:ID Expo, which began here today ... NexID said version 2.0 of its SDK boosts the ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2
... - A Purdue University biochemist has demonstrated a process ... their targets, which may help reduce drug side effects. ... analytical chemistry, developed a nanopolymer that can be coated ... which proteins in the cells the drug has entered. ...
... now open! ,You may apply for a Press ... www.eular.org/congress_press_registration.cfm Scientific Programme , The scientific ... The preliminary programme can be accessed online or downloaded ... Abstracts , Abstracts accepted for presentation are made available ...
... Recycling manure is an important practice, especially for large ... in crop production, aiding livestock producers that grow their own ... for crops, it also can contribute to nutrient leaching and ... eutrophication of waterways. The desire for farmers to be able ...
Cached Biology News:Nanopolymer shows promise for helping reduce cancer side effects 2EULAR 2011 media update 2Cost effective manure management 2
(Date:5/5/2015)... May 5, 2015  Renova™ Therapeutics, a biopharmaceutical ... failure and other chronic diseases, has engaged RAND ... designed to reflect the healthcare patterns of multiple ... will be used to characterize the impact the ... on those groups of patients and the overall ...
(Date:5/5/2015)... -- A group of biotechnology executives and medical doctors announced ... non-profit organization dedicated to providing education, research and therapeutic ... consciousness.  ... Coma is the ... actions can be initiated by the patient, and sleep-wake ...
(Date:5/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/x5gjj3/clinical ) ... Laboratory, Molecular Diagnostics and Genomic Testing Services Market ... Version" report to their offering. ... molecular diagnostics and pharmacogenics hold the promise of ... is moving out of the national and regional ...
(Date:5/5/2015)... , May 5, 2015  Orexigen Therapeutics, Inc. ... the first quarter 2015 on Friday, May 8 before ... a live webcast and conference call at 8:30 a.m. ... live call may be accessed by phone by calling ... 39586962. The webcast can be accessed live on the ...
Breaking Biology Technology:RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 3Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 2Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 3Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 4Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 5Global Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecast 2015 to 2019 2
... Management Solution innovating the way Misukanis & Odden schedule tasks. ... ... Technologies ( http://info.oneplacehome.com ), creators of the ground breaking ... with their video series "A Day In The Life." The newest ...
... Corporation,(Nasdaq: DRRX ) announced today that ... Alpharma Ireland Limited, an affiliate of,Alpharma Inc. ... the exclusive worldwide,rights to develop and commercialize ... review under the,Hart-Scott-Rodino (HSR) Antitrust Improvements Act ...
... Professors Ichijo and Mano Receive 2008 JCA-Mauvernay ... Debiopharm Group,(Debiopharm), a global biopharmaceutical development specialist ... oncology, presented,Professors Hidenori Ichijo and Hiroyuki Mano ... basic and applied research work in oncology.,The ...
Cached Biology Technology:Riverock Technologies Helps Misukanis & Odden Eliminate Task Management Obstacles 2Riverock Technologies Helps Misukanis & Odden Eliminate Task Management Obstacles 3DURECT's Collaboration With Alpharma Clears HSR Review and Is Effective 2DURECT's Collaboration With Alpharma Clears HSR Review and Is Effective 3DURECT's Collaboration With Alpharma Clears HSR Review and Is Effective 4Japanese Cancer Association and Debiopharm Honour Japanese Research 2Japanese Cancer Association and Debiopharm Honour Japanese Research 3
... AmpliTaq DNA Polymerase is the most thoroughly ... a testimony to its overall utility and ... it ideal for PCR applications. , ... results. ,, AmpliTaq DNA Polymerase is ...
... a versatile and easy-to use enzyme, with ... Taq DNA Polymerase is prepared from a ... the DNA polymerase I gene from Thermococcus ... 5'-3' DNA polymerase activity. Its inherent 3'-5' ...
Taq DNA Polymerase (cloned), 250 units. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzymes, Polymerases....
APO(a) EIA Sample Size: 25 l...
Biology Products: